Advertisement

Pathologie pp 201-213 | Cite as

Zystische Nierenerkrankungen und assoziierte Fehlbildungen

  • Carsten BergmannEmail author
Chapter
Part of the Pathologie book series (PATHOL)

Zusammenfassung

Das Kapitel behandelt die klinische und genetische Charakterisierung zystischer Nierenerkrankungen und hiermit assoziierter Krankheitsbilder. Im Detail werden die autosomal-dominante (ADPKD) und rezessive polyzystische Nierenerkrankung (ARPKD) sowie die heterogene Gruppe der Nephronophthisen (NPHP) und medullär-zystischen Nierenerkrankungen besprochen. Es werden zudem Syndrome mit zystischen Nierenveränderungen angesprochen, von denen viele den Ziliopathien angehören. Die aktuelle genetische Diagnostik dieser Erkrankungen wird dargestellt.

Literatur

  1. 1.
    Adeva M, El-Youssef M, Rossetti S (2006) Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine (Baltimore) 85:1–21CrossRefGoogle Scholar
  2. 2.
    Badano JL, Mitsuma N, Beales PL et al (2006) The ciliopathies: an emerging class of human genetic disorders. Annu Rev Genomics Hum Genet 7:125–148CrossRefPubMedGoogle Scholar
  3. 3.
    Bergmann C, Zerres K (2007) Early manifestations of polycystic kidney disease. Lancet 369:2157CrossRefPubMedGoogle Scholar
  4. 4.
    Bergmann C, von Bothmer J, Bruchle N et al (2011) Mutations in multiple PKD genes may explain early and severe polycystic kidney disease. J Am Soc Nephrol 22:2047–2056PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    Bergmann C, Senderek J, Windelen E et al (2005) Clinical consequences of PKHD1 mutations in 164 patients with autosomal recessive polycystic kidney disease (ARPKD). Kidney Int 67:829–848CrossRefPubMedGoogle Scholar
  6. 6.
    Bergmann C (2012) Ciliopathies. Eur J Pediatr 171:1285–300PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Brancati F, Dallapiccola B, Valente EM (2010) Joubert Syndrome and related disorders. Orphanet J Rare Dis 5:20PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    Drenth JP, Chrispijn M, Bergmann C (2010) Congenital fibrocystic liver diseases. Best Pract Res Clin Gastroenterol 24:573–584CrossRefPubMedGoogle Scholar
  9. 9.
    Harris PC, Torres VE (2009) Polycystic kidney disease. Annu Rev Med 60:321–337PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Harris PC, Rossetti S (2010) Molecular diagnostics for autosomal dominant polycystic kidney disease. Nat Rev Nephrol 6:197–206PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Hildebrandt F, Zhou W (2007) Nephronophthisis-associated ciliopathies. J Am Soc Nephrol 18:1855–1871CrossRefPubMedGoogle Scholar
  12. 12.
    Hildebrandt F, Benzing T, Katsanis N (2011) Ciliopathies. N Engl J Med 364:1533–1543PubMedCentralCrossRefPubMedGoogle Scholar
  13. 13.
    Kuroda N, Ohe C, Mikami S, Hes O, Michal M, Brunelli M, Martignoni G, Sato Y, Yoshino T, Kakehi Y, Shuin T, Lee GH (2011) Review of acquiredcysticdisease-associated renal cell carcinoma with focus on pathobiological aspects. Histol Histopathol 26:1215–1218PubMedGoogle Scholar
  14. 14.
    Metzker ML (2010) Sequencing technologies – the next generation. Nat Rev Genet 11:31–46CrossRefPubMedGoogle Scholar
  15. 15.
    Omran H (2008) Nephronophthis and medullary cystic kidney disease. In: Geary DF, Schaefer F (Hrsg) Comprehensive pediatric nephrology. Elsevier, Amsterdam, S 143–154CrossRefGoogle Scholar
  16. 16.
    Plotnikova OV, Golemis EA, Pugacheva EN (2008) Cell cycle-dependent ciliogenesis and cancer. Cancer Res 68:2058–2061PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Rosenbaum JL, Witman GB (2002) Intraflagellar transport. Nat Rev Mol Cell Biol 3:813–825CrossRefPubMedGoogle Scholar
  18. 18.
    Rossetti S, Kubly VJ, Consugar MB, Hopp K, Roy S, Horsley SW, Chauveau D, Rees L, Barratt TM, van’t Hoff WG, Niaudet WP, Torres VE, Harris PC (2009) Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney Int 75:848–855PubMedCentralCrossRefPubMedGoogle Scholar
  19. 19.
    Torres VEHPC (2009) Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 76:149–168PubMedCentralCrossRefPubMedGoogle Scholar
  20. 20.
    Torres VE (2010) Treatment strategies and clinical trial design in ADPKD. Adv Chronic Kidney Dis 17:190–204PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Zaghloul NA, Katsanis N (2009) Mechanistic insights into Bardet-Biedl syndrome, a model ciliopathy. J Clin Invest 119:428–437PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  1. 1.Zentrum HumangenetikBioscientiaIngelheimDeutschland

Personalised recommendations